Skip to main content
. 2013 Nov 12;14:249. doi: 10.1186/1471-2369-14-249

Table 3.

Percentages of incident hemodialysis and peritoneal dialysis patients with prescriptions for specific blood pressure medications at 6 months by cardiovascular risk factor or disease, 2003-2008

 
Hemodialysis, n= 12,159
Peritoneal dialysis, n= 913
 
 
CHF
CVD
Diabetes
 
CHF
CVD
Diabetes
Medication All Yes No Yes No Yes No All Yes No Yes No Yes No
None
12
10
13
11
13
10
15
10
7
10
7
11
5
14
Beta-blocker
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Any
59
65
55
64
53
62
54
55
69
51
67
48
61
48
  Alpha-beta
19
26
13
22
15
20
16
13
25
10
17
11
16
10
  Beta not alpha
41
39
42
43
38
42
38
42
44
41
51
37
45
38
RAS *
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Any
45
45
45
44
46
49
39
52
54
51
55
50
57
46
  ACEI
32
32
31
31
32
34
27
33
36
32
34
32
35
30
  ARB
17
16
17
16
18
19
14
23
22
23
25
22
26
19
CCB
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Any
49
44
52
45
52
49
47
50
43
51
48
51
54
44
  DHP
40
36
43
37
43
41
39
40
35
41
38
41
42
37
  Non-DHP
9
8
9
8
9
9
8
10
8
10
10
10
13
7
Diuretic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Any
28
31
24
28
26
31
21
41
55
37
52
35
50
32
  Loop
26
30
22
26
24
29
19
38
53
34
50
33
47
29
  Thiazide
5
5
4
4
5
5
3
9
13
8
13
6
12
5
Alpha blocker
7
6
7
7
6
7
7
10
8
10
12
9
11
7
Central alpha 2 agonist
19
18
20
17
21
20
18
15
14
16
14
16
16
14
Hydralazine
8
11
6
9
7
9
7
4
9
3
5
4
6
3
Minoxidil 4 3 4 3 5 4 5 2 2 3 1 3 2 2

Note: Values are percentages except for the n row, which represents number of individuals.

ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DHP, dihydropyridine; RAS, renin angiotensin system agent.

*Renin-inhibitors comprised < 1% of RAS agents from 2003–2008.

Potassium-sparing diuretics comprised < 1% of diuretic agents from 2003–2008.